UNSPSC 85812112: Introduction of monoclonal antibody into eye, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of monoclonal antibody into eye, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0C30M

UNSPSC 85812112 Introduction of monoclonal antibody into eye, percutaneous approach is a Commodity code that shows minimal relevance to the recent state and local procurement opportunities indexed under it. The recent solicitations tagged to this code—including virtual urgent care services, medical services, Program of All Inclusive Care for the Elderly, occupational health services, cancer screening, employee wellness platforms, and numerous clinical staffing and administrative health contracts—do not align with the code's specific clinical procedure scope. The mismatch reflects a tagging inconsistency in the underlying procurement databases rather than genuine demand for monoclonal antibody injection procedures through state and local channels.

State and local government procurement under this code shows no documented recent activity. The opportunities surface across diverse issuing bodies including county health systems (Santa Clara County, San Mateo County), state health authorities (Nevada Health Authority), state departments (Colorado Department of Human Services, Texas Health and Human Services Commission), and municipal agencies (City of Phoenix, City of Ocala), but none solicit the procedural or pharmaceutical service the code describes. Geographic spread is broad—California, Colorado, Florida, Georgia, Kansas, Missouri, Nevada, New Jersey, New York, Oregon, Texas, and Washington—yet activity remains disconnected from the code's definition. This code is not a current business development priority for firms pursuing state and local health service contracts.